Early- and late anthracycline-induced cardiac dysfunction: echocardiographic characterization and response to heart failure therapy

BACKGROUND: Anthracycline-induced cardiac dysfunction (ACD) is a notorious side effect of anticancer treatment. It has been described as a phenomenon of a continuous progressive decline of cardiac function, eventually leading to dilated cardiomyopathy (DCM). This progressive nature suggests that pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamphuis, Janine A. M., Linschoten, Marijke, Cramer, Maarten J., Doevendans, Pieter A., Asselbergs, Folkert W., Teske, Arco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557080/
https://www.ncbi.nlm.nih.gov/pubmed/33072403
http://dx.doi.org/10.1186/s40959-020-00079-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557080/
https://www.ncbi.nlm.nih.gov/pubmed/33072403
http://dx.doi.org/10.1186/s40959-020-00079-3

Ejemplares similares